Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature

被引：9
作者：
Raiss, Hanan [1 ,2 ]
Peron, Julien [3 ,4 ]
Tartas, Sophie [3 ,4 ]
Trillet-Lenoir, Veronique [3 ,4 ]
Freyer, Gilles [3 ,4 ]
Errihani, Hassan [1 ,2 ]
机构：
[1] CHU Rabat, Serv Oncol Med, Inst Natl Oncol, Ave Allal Al Fassi, Rabat 10000, Morocco
[2] Univ Mohammed 5, Ave Allal Al Fassi, Rabat 10000, Morocco
[3] Hosp Civils Lyon, Inst Cancerol, Pierre Benite, France
[4] Univ Lyon, Pierre Benite, France
来源：
CLINICAL BREAST CANCER | 2018年 / 18卷 / 03期
关键词：
Anemia; Drug-induced TMA; Palbociclib; Thrombocytopenia; Thrombotic microangiopathy (TMA); 1ST-LINE TREATMENT; COMBINATION; LETROZOLE; PALOMA-1/TRIO-18; FULVESTRANT; INHIBITOR; TRIAL;
D O I：
10.1016/j.clbc.2017.10.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E263 / E266
页数：4
相关论文
共 18 条
[1]   Drug-induced thrombotic microangiopathy: a systematic review of published reports [J].
Al-Nouri, Zayd L. ;
Reese, Jessica A. ;
Terrell, Deirdra R. ;
Vesely, Sara K. ;
George, James N. .
BLOOD, 2015, 125 (04) :616-618
[2]   Cancer-associated thrombotic microangiopathy [J].
Babu, Govind K. ;
Bhat, Gita R. .
ECANCERMEDICALSCIENCE, 2016, 10
[3]   Thrombotic Microangiopathy with Targeted Cancer Agents [J].
Blake-Haskins, John A. ;
Lechleider, Robert J. ;
Kreitman, Robert J. .
CLINICAL CANCER RESEARCH, 2011, 17 (18) :5858-5866
[4]  
Bowles Harmony J, 2015, J Adv Pract Oncol, V6, P577
[5]   VWF meets the ADAMTS family [J].
Brass, L .
NATURE MEDICINE, 2001, 7 (11) :1177-1178
[6]   Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial [J].
Cristofanilli, Massimo ;
Turner, Nicholas C. ;
Bondarenko, Igor ;
Ro, Jungsil ;
Im, Seock-Ah ;
Masuda, Norikazu ;
Colleoni, Marco ;
DeMichele, Angela ;
Loi, Sherene ;
Verma, Sunil ;
Iwata, Hiroji ;
Harbeck, Nadia ;
Zhang, Ke ;
Theall, Kathy Puyana ;
Jiang, Yuqiu ;
Bartlett, Cynthia Huang ;
Koehler, Maria ;
Slamon, Dennis .
LANCET ONCOLOGY, 2016, 17 (04) :425-439
[7]   Palbociclib and Letrozole in Advanced Breast Cancer [J].
Finn, Richard S. ;
Martin, Miguel ;
Rugo, Hope S. ;
Jones, Stephen ;
Im, Seock-Ah ;
Gelmon, Karen ;
Harbeck, Nadia ;
Lipatov, Oleg N. ;
Walshe, Janice M. ;
Moulder, Stacy ;
Gauthier, Eric ;
Lu, Dongrui R. ;
Randolph, Sophia ;
Dieras, Veronique ;
Slamon, Dennis J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20) :1925-1936
[8]   Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18 [J].
Finn, Richard S. ;
Crown, John P. ;
Ettl, Johannes ;
Schmidt, Marcus ;
Bondarenko, Igor M. ;
Lang, Istvan ;
Pinter, Tamas ;
Boer, Katalin ;
Patel, Ravindranath ;
Randolph, Sophia ;
Kim, Sindy T. ;
Huang, Xin ;
Schnell, Patrick ;
Nadanaciva, Sashi ;
Bartlett, Cynthia Huang ;
Slamon, Dennis J. .
BREAST CANCER RESEARCH, 2016, 18
[9]   The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study [J].
Finn, Richard S. ;
Crown, John P. ;
Lang, Istvan ;
Boer, Katalin ;
Bondarenko, Igor M. ;
Kulyk, Sergey O. ;
Ettl, Johannes ;
Patel, Ravindranath ;
Pinter, Tamas ;
Schmidt, Marcus ;
Shparyk, Yaroslav ;
Thummala, Anu R. ;
Voytko, Nataliya L. ;
Fowst, Camilla ;
Huang, Xin ;
Kim, Sindy T. ;
Randolph, Sophia ;
Slamon, Dennis J. .
LANCET ONCOLOGY, 2015, 16 (01) :25-35
[10]  
George JN, 2014, NEW ENGL J MED, V371, P1847, DOI [10.1056/NEJMra1312353, 10.1056/NEJMc1410951]
12